Wulff Jörg, Koska Benjamin, Janson Martin, Bäumer Christian, Denker Andrea, Geismar Dirk, Gollrad Johannes, Timmermann Beate, Heufelder Jens
West German Proton Therapy Centre Essen (WPE), Essen, Germany.
University Hospital Essen, Essen, Germany.
Med Phys. 2022 May;49(5):3481-3488. doi: 10.1002/mp.15573. Epub 2022 Mar 8.
To evaluate the impact of beam quality in terms of distal fall-off (DFO, 90%-10%) and lateral penumbra (LP, 80%-20%) of single beam ocular proton therapy (OPT) and to derive resulting ideal requirements for future systems.
Nine different beam models with DFO varying between 1 and 4 mm and LP between 1 and 4 mm were created. Beam models were incorporated into the RayStation with RayOcular treatment planning system version 10 B (RaySearch Laboratories, Stockholm, Sweden). Each beam model was applied for eight typical clinical cases, covering different sizes and locations of uveal melanoma. Plans with and without an additional wedge were created, resulting in 117 plans with a total prescribed median dose of 60 Gy(RBE) to the clinical target volume. Treatment plans were analyzed in terms of V20-V80 penumbra volume, D1 (dose to 1% of the volume) for optic disc and macula, optic nerve V30 (volume receiving 30 Gy(RBE), i.e., 50% of prescription), as well as average dose to lens and ciliary body. An LP-dependent aperture margin was based on estimated uncertainties, ranging from 1.7 to 4.0 mm.
V20-V80 showed a strong influence by LP, while DFO was less relevant. The optic disc D1 reached an extra dose of up to 3000 cGy(RBE), comparing the defined technical limit of DFO = LP = 1 mm with DFO = 3 mm/LP = 4 mm. The latter may result from a pencil-beam scanning (PBS) system with static apertures. Plans employing a wedge showed an improvement for organs at risk sparing.
Plan quality is strongly influenced by initial beam parameters. The impact of LP is more pronounced when compared to DFO. The latter becomes important in the treatment of posterior tumors near the macula, optic disc or optic nerve. The plan quality achieved by dedicated OPT nozzles in single- or double-scattering design might not be achievable with modified PBS systems.
评估单束眼质子治疗(OPT)中射野远端剂量下降(DFO,90%-10%)和侧向半值层(LP,80%-20%)方面的射束质量影响,并得出对未来系统的理想要求。
创建了9种不同的射束模型,DFO在1至4毫米之间变化,LP在1至4毫米之间变化。将射束模型纳入带有RayOcular治疗计划系统版本10 B(瑞典斯德哥尔摩RaySearch Laboratories公司)的RayStation中。每个射束模型应用于8个典型临床病例,涵盖不同大小和位置的葡萄膜黑色素瘤。创建了有和没有额外楔形板的计划,从而产生了117个计划,临床靶体积的总处方中位剂量为60 Gy(RBE)。根据V20-V80半值层体积、视盘和黄斑的D1(1%体积的剂量)、视神经V30(接受30 Gy(RBE)的体积,即处方的50%)以及晶状体和睫状体的平均剂量对治疗计划进行分析。基于估计的不确定性,LP相关的孔径边缘范围为1.7至4.0毫米。
V20-V80受LP影响很大,而DFO的相关性较小。将DFO = LP = 1毫米的定义技术极限与DFO = 3毫米/LP = 4毫米进行比较时,视盘D1额外剂量高达3000 cGy(RBE)。后者可能源于具有静态孔径的笔形束扫描(PBS)系统。采用楔形板的计划在危及器官的 sparing方面显示出改善。
计划质量受初始射束参数强烈影响。与DFO相比,LP的影响更明显。后者在治疗黄斑、视盘或视神经附近的后部肿瘤时变得很重要。通过单散射或双散射设计的专用OPT喷嘴实现的计划质量可能无法通过改进的PBS系统实现。